H.R. 4396 · 114th Congress
Heroin and Prescription Drug Abuse Prevention and Reduction Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 114th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
PalloneSponsor34 cosponsors · 34 D
D
Ashford
YC
D
Clarke
JK
D
Kennedy
DL
D
Loebsack
BL
D
Luján
DM
D
Matsui
PT
D
Tonko
AG
D
Grayson
EJ
D
Johnson
JY
D
Yarmuth
TD
D
Deutch
EE
D
Engel
DP
D
Payne
CV
D
Van Hollen
TC
D
Cárdenas
EN
D
Norton
JS
D
Schakowsky
MT
D
Takano
EB
D
Blumenauer
DD
D
DeGette
TD
D
Duckworth
MD
D
DeSaulnier
DK
D
Kilmer
CP
D
Pingree
PW
D
Welch
LC
D
Capps
GM
D
Moore
CR
D
Rangel
AH
D
Hastings
MK
D
Kaptur
SL
D
Levin
ES
D
Swalwell
BW
D
Watson Coleman
MD
D
Doyle0 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Heroin and Prescription Drug Abuse Prevention and Reduction Act
What it does: CRS summary · Introduced in House · Jan 28, 2016
Heroin and Prescription Drug Abuse Prevention and Reduction Act
This bill amends the Controlled Substances Act to revise requirements for and limitations on practitioners who dispense narcotic drugs for maintenance or detoxification treatment.
The Department of Health and Human Services (HHS) must establish grant programs to: (1) encourage prescribing and purchase of opioid overdose reversal drugs (e.g., naloxone), and (2) develop prescribing guidelines for such drugs. (Opioids are drugs with effects similar to opium, such as heroin or certain pain medications.)
The Centers for Disease Control and Prevention must provide support to improve drug overdose surveillance and reporting capabilities.
HHS may support syringe exchange programs.
The Substance Abuse and Mental Health Services Administration must provide support to: (1) reduce drug overdose deaths; and (2) develop, expand, and enhance substance use recovery support services.
This bill amends the Public Health Service Act to extend residential treatment programs for pregnant and postpartum women.
The Center for Substance Abuse Treatment must: (1) carry out a pilot program to support services for pregnant and postpartum women with a substance use disorder; (2) award grants to expand treatment activities in areas with a high rate of, or a rapid increase in, the use of opioids; and (3) support increasing the capacity of substance use disorder services for adolescents.
This bill amends the Employee Retirement Income Security Act of 1974 (ERISA) and Internal Revenue Code to direct HHS and the Departments of Labor and the Treasury to require disclosures, issue guidance, conduct audits, and publish information regarding the requirement for group health plans and health insurance coverage to have parity between mental health and substance use disorder benefits and medical and surgical benefits. HHS must establish a consumer parity portal website.
HHS must establish a loan repayment program for substance use disorder health professionals.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Heroin and Prescription Drug Abuse Prevention and Reduction Act
Latest action (Mar 23, 2016): Referred to the Subcommittee on Health, Employment, Labor, and Pensions.
Policy area: Health · Origin: House · Introduced: Jan 28, 2016
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.